IL59978A - 2-aminoalkyl-5-pyridinols,their manufacture and pharmaceutical compositions containing them - Google Patents
2-aminoalkyl-5-pyridinols,their manufacture and pharmaceutical compositions containing themInfo
- Publication number
- IL59978A IL59978A IL59978A IL5997880A IL59978A IL 59978 A IL59978 A IL 59978A IL 59978 A IL59978 A IL 59978A IL 5997880 A IL5997880 A IL 5997880A IL 59978 A IL59978 A IL 59978A
- Authority
- IL
- Israel
- Prior art keywords
- formula
- xii
- carboxylic acid
- image
- pyridinols
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Building Environments (AREA)
- Paper (AREA)
Abstract
There is described a process for preparing an enamine of formula (IX): <IMAGE> where R<2> is a carboxylic acid protecting group and R<3> is the residue of a carboxylic acid derived acyl group and where R<5> and R<6> are the same or different C1-4 alkyl or C1-10 aralkyl groups; or taken together with the adjacent nitrogen atom form a heterocyclic ring containing from 4 to 8 carbon atoms and optionally a further heteroatom selected from oxygen and nitrogen; by reacting a compound of formula (XII): <IMAGE> with an amine of formula HNR<5>R<6>, the reactant of formula (XII) being prepared by reaction of an appropriate enol derivative with a phosphorus reagent. The enamines of formula (IX) are useful in the preparation of 3- hydroxycephalosporins. The compounds of formula (XII) are novel.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3566879A | 1979-05-03 | 1979-05-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL59978A0 IL59978A0 (en) | 1980-07-31 |
IL59978A true IL59978A (en) | 1984-03-30 |
Family
ID=21884070
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL59978A IL59978A (en) | 1979-05-03 | 1980-05-01 | 2-aminoalkyl-5-pyridinols,their manufacture and pharmaceutical compositions containing them |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0019739B1 (en) |
JP (1) | JPS55149260A (en) |
AT (1) | ATE8501T1 (en) |
DD (1) | DD150461A5 (en) |
DE (1) | DE3068577D1 (en) |
DK (1) | DK157540C (en) |
ES (1) | ES491055A0 (en) |
FI (1) | FI70212C (en) |
GB (1) | GB2050380B (en) |
GR (1) | GR68206B (en) |
HU (1) | HU181115B (en) |
IE (1) | IE49712B1 (en) |
IL (1) | IL59978A (en) |
MA (1) | MA18964A1 (en) |
NO (1) | NO154130C (en) |
OA (1) | OA06528A (en) |
PL (1) | PL223984A1 (en) |
PT (1) | PT71176A (en) |
ZW (1) | ZW9680A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4746670A (en) * | 1986-04-11 | 1988-05-24 | Ciba-Geigy Corporation | Use of 2-aminoalkyl-5-pyridinols as nootropic agents and antidepressants |
JP4732662B2 (en) * | 2000-04-06 | 2011-07-27 | セイコーインスツル株式会社 | Battery holding structure for electronic watch |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3952101A (en) * | 1975-04-14 | 1976-04-20 | Smithkline Corporation | α-Amino methyl-5-hydroxy-2-pyridinemethanols |
-
1980
- 1980-04-30 ES ES491055A patent/ES491055A0/en active Granted
- 1980-04-30 HU HU80801080A patent/HU181115B/en not_active IP Right Cessation
- 1980-04-30 NO NO801267A patent/NO154130C/en unknown
- 1980-04-30 AT AT80102347T patent/ATE8501T1/en not_active IP Right Cessation
- 1980-04-30 DE DE8080102347T patent/DE3068577D1/en not_active Expired
- 1980-04-30 FI FI801411A patent/FI70212C/en not_active IP Right Cessation
- 1980-04-30 ZW ZW96/80A patent/ZW9680A1/en unknown
- 1980-04-30 PT PT71176A patent/PT71176A/en unknown
- 1980-04-30 EP EP80102347A patent/EP0019739B1/en not_active Expired
- 1980-05-01 IL IL59978A patent/IL59978A/en unknown
- 1980-05-01 DK DK193180A patent/DK157540C/en not_active IP Right Cessation
- 1980-05-02 MA MA19024A patent/MA18964A1/en unknown
- 1980-05-02 GB GB8014705A patent/GB2050380B/en not_active Expired
- 1980-05-02 IE IE899/80A patent/IE49712B1/en not_active IP Right Cessation
- 1980-05-02 JP JP5800280A patent/JPS55149260A/en active Granted
- 1980-05-02 GR GR61845A patent/GR68206B/el unknown
- 1980-05-02 DD DD80220844A patent/DD150461A5/en not_active IP Right Cessation
- 1980-05-03 OA OA57107A patent/OA06528A/en unknown
- 1980-05-03 PL PL22398480A patent/PL223984A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JPS6365662B2 (en) | 1988-12-16 |
FI70212B (en) | 1986-02-28 |
EP0019739B1 (en) | 1984-07-18 |
ES8104229A1 (en) | 1981-04-01 |
ZW9680A1 (en) | 1980-11-26 |
HU181115B (en) | 1983-06-28 |
IE800899L (en) | 1980-11-03 |
MA18964A1 (en) | 1980-12-31 |
IL59978A0 (en) | 1980-07-31 |
FI801411A (en) | 1980-11-04 |
NO801267L (en) | 1980-11-04 |
EP0019739A1 (en) | 1980-12-10 |
DK157540B (en) | 1990-01-22 |
DE3068577D1 (en) | 1984-08-23 |
PL223984A1 (en) | 1981-02-13 |
IE49712B1 (en) | 1985-11-27 |
GR68206B (en) | 1981-11-10 |
GB2050380A (en) | 1981-01-07 |
GB2050380B (en) | 1983-07-20 |
JPS55149260A (en) | 1980-11-20 |
DD150461A5 (en) | 1981-09-02 |
ES491055A0 (en) | 1981-04-01 |
OA06528A (en) | 1981-07-31 |
FI70212C (en) | 1986-09-15 |
PT71176A (en) | 1980-05-01 |
ATE8501T1 (en) | 1984-08-15 |
NO154130B (en) | 1986-04-14 |
DK193180A (en) | 1980-11-04 |
NO154130C (en) | 1986-07-23 |
DK157540C (en) | 1990-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3171467D1 (en) | Mannich-base hydroxamic acid prodrugs for the improved bioavailability of non-steroidal anti-inflammatory agents, a process for preparing and a pharmaceutical composition containing them | |
IL68075A0 (en) | Pyridine and pyrane derivatives,their preparation and pharmaceutical compositions containing them | |
ES8104286A1 (en) | 1,8-Naphthyridine derivatives, their preparation, pharmaceutical compositions containing them. | |
ES8301927A1 (en) | Substituted azobicyclooctanecarboxylic acids, process for their preparation und pharmaceutical compositions containing them. | |
HUT46895A (en) | Process for production of new 5-lipoxigenase bicyclic compounds with inhibiation effect | |
ES8104309A1 (en) | Process for preparing enamine derivatives, compounds so produced and process for preparing a 3-hydroxy-cephalosporin. | |
IL59978A (en) | 2-aminoalkyl-5-pyridinols,their manufacture and pharmaceutical compositions containing them | |
ES8609195A1 (en) | Process for preparing anti-inflammatory cycloalkylidenemethylphenylacetic acid derivatives. | |
ES8401059A1 (en) | Bicyclic phenol ethers, process for their preparation and medicines containing these compounds. | |
GB871235A (en) | Novel substituted pyrrolidones and salts thereof and a process for the manufacture of same | |
EG14458A (en) | Branched salkyl phosphonodithioic halide intermediates and process for their production | |
ES473484A1 (en) | A procedure for the preparation of new eteres of the clavulan acid (Machine-translation by Google Translate, not legally binding) | |
IL59046A (en) | Process for the preparation of 7-sulfonimidoyl xanthone-2-carboxylic acid derivatives |